{"version":"1.0","type":"link","title":"Refining Tumor Mutational Burden as a Predictive Biomarker for Pembrolizumab: A Real-World Analysis in Japanese Patients.","author_name":"Yasuda T 외","author_url":"https://prs-insight.online/author/Yasuda%20T","provider_name":"PRSinsight","provider_url":"https://prs-insight.online","thumbnail_url":"https://prs-insight.online/og/paper/167282","thumbnail_width":1200,"thumbnail_height":630}